[The gut microbiota, a new cardiovascular risk factor?]

Area of Science:

• Microbiology
• Metabolic Science
• Cardiovascular Science

Background:

• The gut microbiota plays a crucial role in regulating physiological metabolism.
• Gut microbiota metabolites, such as trimethylamine N-oxide (TMAO), are linked to cardiovascular disease (CVD) risk.
• Bile acids offer protective effects against CVD through anti-inflammatory and anti-atherogenic properties.

Purpose of the Study:

• To explore the role of gut microbiota in metabolic regulation and cardiovascular health.
• To understand the implications of gut microbiota dysbiosis in metabolic and cardiovascular diseases.
• To identify potential therapeutic strategies targeting the gut microbiota for disease management.

Main Methods:

• Analysis of gut microbiota composition and function.
• Measurement of circulating metabolite levels (e.g., TMAO, bile acids).
• Correlation studies between microbiota profiles, metabolites, and disease outcomes.

Main Results:

• Gut microbiota dysbiosis is associated with altered metabolite profiles.
• Elevated TMAO levels correlate with increased cardiovascular event occurrence.
• Bile acid metabolism is interconnected with gut microbiota composition and CVD risk.

Conclusions:

• The gut microbiota is a significant factor in metabolic and cardiovascular health.
• TMAO and bile acids are key microbial metabolites influencing cardiovascular risk.
• Targeting gut microbiota dysbiosis presents a promising avenue for managing metabolic and cardiovascular diseases.